Government

FDA
The game was reviewed through the agency’s de novo pathway and as a result, creates a new class of digital therapeutics.
The warning came only a few hours after the FDA rescinded Emergency Use Authorization (EUA) for hydroxychloroquine and chloroquine for the treatment of COVID-19.
FDA
The approval was based on monotherapy clinical data from a trial in 105 adults with SCLC whose disease progressed after platinum-based chemotherapy.
FDA
The FDA indicated that, based on new evidence, there was not enough supporting evidence for the two drugs to be considered effective in treating COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 15, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 12, 2020.
In an interview this morning with CNN, Dr. Anthony Fauci said the government will help finance Phase III studies of three vaccine candidates.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 10, 2020.
Fauci, a longtime infectious disease expert, said COVID-19 is the stuff of nightmares in the way it has quickly spread across the globe, infected millions of people and contributed to the deaths of more than 408,000 people.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
PRESS RELEASES